Sanoj Punnen, MD, MAS, discusses the limitations of multiparametric MRI (mpMRI) and genomic biomarkers in selecting men with intermediate or high-risk prostate cancer for active surveillance. He suggests that combining mpMRI and genomics may allow for more accurate risk-stratification, focusing on preliminary data from the Miami MAST trial.
Read More
Michael A. Brooks, MD, discusses the practical advantages and limitations of the recently FDA-approved da Vinci Single Port (SP) robotic system for urologic procedures. He reviews surgical videos of pyeloplasty, retropubic radical prostatectomy, and perineal salvage prostatectomy procedures using this system.
Read More
Gerald L. Andriole, Jr., MD, discusses the unmet need for precise imaging of biochemical recurrent prostate cancer. He reviews data on imaging agents, especially 18F-fluciclovine PET/CT, ¹¹C-choline PET/CT, and 68Ga-PSMA-11, and deliberates on the impact of imaging-guided treatment changes on patient outcomes.
Read More
Christopher P. Smith, MD, MBA, MSS, reviews management recommendations from the 6th International Consultation on Incontinence guidelines, as well as recent literature on the treatment of male stress urinary incontinence. He discusses treatment approaches, including urethral bulking agents, male slings, artificial urinary sphincter, and adjustable balloons.
Read More
Christopher P. Smith, MD, MBA, MSS, describes the treatment pathway for advanced overactive bladder (OAB) patients as described in the American Urological Association (AUA)/ Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) OAB guidelines. He discusses novel treatment approaches, including rechargeable sacral neuromodulation devices, implantable tibial nerve stimulators, bladder denervation, and transcutaneous stimulation of the tibial nerves.
Read More